Zinc glycinate
CAS 14281-83-5
Zinc glycinate (CAS 14281-83-5) is a pharmaceutical compound with 0 bioactivity targets and 7 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Zinc glycinate is linked to DTXSID60162193 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| zinc glycinate | 1306063 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Zinc glycinate used for in pharmaceutical contexts?
Zinc glycinate (CAS 14281-83-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Zinc glycinate?
Zinc glycinate has 7 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Drug ineffective, Headache, Aggression, Anxiety, Depression. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Zinc glycinate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for ZINC GLYCINATE with EU status "restricted".
What clinical phase is Zinc glycinate in?
No phase 1-4 clinical development badge is rendered for Zinc glycinate because the matched compound identifier rows do not contain a max-phase value.